{"id":532396,"date":"2021-03-02T19:02:01","date_gmt":"2021-03-02T19:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=532396"},"modified":"2021-03-02T19:02:01","modified_gmt":"2021-03-02T19:02:01","slug":"degenerative-disc-disease-market-industry-analysis-and-growth-size-share-trends-opportunities-top-key-players-discgenics-mesoblastgruenthal-kuros-biosciences-ankasa-therapeutics-etc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/degenerative-disc-disease-market-industry-analysis-and-growth-size-share-trends-opportunities-top-key-players-discgenics-mesoblastgruenthal-kuros-biosciences-ankasa-therapeutics-etc_532396.html","title":{"rendered":"Degenerative Disc Disease Market &#8211; Industry Analysis and Growth &#8211; Size, Share, Trends, Opportunities, Top Key Players DiscGenics, Mesoblast\/Gruenthal, Kuros Biosciences, Ankasa Therapeutics, etc"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1614658340.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Degenerative Disc Disease Market - Industry Analysis and Growth - Size, Share, Trends, Opportunities, Top Key Players DiscGenics, Mesoblast\/Gruenthal, Kuros Biosciences, Ankasa Therapeutics, etc\" src=\"https:\/\/www.abnewswire.com\/uploads\/1614658340.png\" alt=\"Degenerative Disc Disease Market - Industry Analysis and Growth - Size, Share, Trends, Opportunities, Top Key Players DiscGenics, Mesoblast\/Gruenthal, Kuros Biosciences, Ankasa Therapeutics, etc\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Degenerative Disc Disease Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">(Albany, US) DelveInsight&#8217;s &#8220;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Degenerative Disc Disease Market Insights, Epidemiology, and Market Forecast-2030<\/a><\/strong>&#8221; report delivers an in-depth understanding of the Degenerative Disc Disease (DDD) , historical and forecasted epidemiology as well as the Degenerative Disc Disease (DDD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Degenerative Disc Disease Facts:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Daily activities and sports causes tears in the outer core of the disc. By age 60, most people have some degree of disc degeneration. However, not everyone at that age has back pain.<\/li>\n<li>The increase in Market Size is mainly expected to be driven by increasing incident pool, rising funding, clinical trials of degenerative disk disease and expected entries of emerging therapies in the 7MM.<\/li>\n<li>Chronic low back pain (CLBP) affects approximately 10-15% of the adult population, equivalent to more than 30 million people in the United States and almost 40 million people across the EU5.<\/li>\n<li>According to a study conducted by Tao et al. (2020), Commonly, 53.9% (n = 852; 386 males, 466 females; mean age = 52.3 &plusmn; 16.6 years) of all the subjects presented with radiographic cervical disc degeneration, and the prevalence of disc degeneration was not significantly different between males and females (53.4 vs. 54.3%, p = 0.72). 36.8% of the subjects had Grade 1 (mild degeneration) disc degeneration, 13.7% had Grade 2 (moderate degeneration) and 3.4% had Grade 3 (severe degeneration).<\/li>\n<li>As per findings from secondary domain, females are most commonly affected in case of Degenerative Disk Disease.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Get more comprehensive insights into how <\/strong><strong>Degenerative Disk Disease<\/strong><strong> epidemiological trends are impacting current and forecasted <\/strong><strong>Degenerative Disk Disease<\/strong><strong> market @&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/degenerative-disc-disease-ddd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Degenerative Disk Disease Epidemiology Analysis and Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Degenerative Disk Disease Key Players<\/strong><strong>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>DiscGenics<\/li>\n<li>Mesoblast\/Gruenthal<\/li>\n<li>Kuros Biosciences<\/li>\n<li>Ankasa Therapeutics<\/li>\n<li>Biorestorative Therapies<\/li>\n<li>AnGes<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Copy:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/degenerative-disc-disease-ddd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/degenerative-disc-disease-ddd-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Degenerative Disk Disease<\/a><\/strong> (DDD- osteochondrosis intervertebralis) is a common disorder that is characterized by a progressive degeneration of the intervertebral disc; rendering them deformed and mechanically dysfunctional. It is a catchall phrase for a number of structural changes of the spine, such as loss of disc height, disc bulges, hydration, and impingement of nerves in the spine, among others.<\/p>\n<p style=\"text-align: justify;\">Resultant loss of structural and functional integrity of the spine can lead to lumbar and\/or cervical pain syndromes; the discs are unable to fulfill their primary functions of cushioning and providing mobility between the vertebrae; consequently DDD has been reported as a leading cause of low back pain. Disc degeneration, although in many cases asymptomatic, is also associated with sciatica and disc herniation or prolapse.<\/p>\n<p style=\"text-align: justify;\"><strong>Degenerative Disk Disease Symptoms<\/strong><\/p>\n<p style=\"text-align: justify;\">Symptoms of degenerative disc disease are most commonly found in the low back or neck. The pain may range from mild to severe and disabling, primarily affect the neck and lower back, extend to the arms and hands, radiate to the buttocks and thighs, worsen when sitting or after bending, lifting or twisting, cause weakness in the leg muscles or foot drop, which may be a sign of damage to the nerve root.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Degenerative Disk Disease Emerging Therapies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>IDCT<\/li>\n<li>Rexlemestrocel<\/li>\n<li>Fibrin-PTH (KUR-113)<\/li>\n<li>ART352-L<\/li>\n<li>BRTX-100<\/li>\n<li>AMG0103<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Do you want to know how much market share the emerging therapies are going to capture by 2030? Contact<\/strong>&nbsp;@&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/degenerative-disc-disease-ddd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Degenerative Disk Disease Marketed Therapies and Treatment<\/a> Approaches and get a comprehensive understanding of the Degenerative Disk Disease therapeutic outlook.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1. Key Insights<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>2. Executive Summary of Degenerative Disk Disease<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3. Competitive Intelligence Analysis for Degenerative Disk Disease<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>4. Degenerative Disk Disease: Market Overview at a Glance<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>5. Degenerative Disk Disease: Disease Background and Overview<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6. Patient Journey<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7. Degenerative Disk Disease Epidemiology and Patient Population<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8. Treatment Algorithm, Current Treatment, and Medical Practices<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9. Unmet Needs<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10. Key Endpoints of Degenerative Disk Disease Treatment<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>11. Marketed Products<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12. Emerging Therapies<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>13. Degenerative Disk Disease: Seven Major Market Analysis<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>14. Attribute analysis<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>15. 7MM: Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>16. Access and Reimbursement Overview of Degenerative Disk Disease<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>17. KOL Views<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>18. Market Drivers<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>19. Market Barriers<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>20. Appendix<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>21. DelveInsight Capabilities<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>22. Disclaimer<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>23. About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Copy:&nbsp;https:\/\/www.delveinsight.com\/sample-request\/helicobacter-pylori-infections-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>CAR-T Cell Therapy For Multiple Myeloma Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &lsquo;<strong>CAR T-Cell Therapy for Multiple Myeloma-Market Insights and Market Forecast-2030<\/strong>&lsquo; report delivers an in-depth understanding of the CAR T-Cell Therapy use for Multiple Myeloma as well as the CAR T-Cell Therapy market trends for Multiple Myeloma in the 6MM i.e.,&nbsp;United States&nbsp;and EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France&nbsp;and the&nbsp;United Kingdom).<\/p>\n<p style=\"text-align: justify;\"><strong>CAR-T Cell Therapy For Non-Hodgkin&rsquo;s Lymphoma Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &lsquo;<strong>CAR T-Cell Therapy for Non-Hodgkin&rsquo;s lymphoma (NHL) &ndash; Market Insights and Market Forecast-2030<\/strong>&lsquo; report delivers an in-depth understanding of the CAR T-Cell Therapy for Non-Hodgkin&rsquo;s lymphoma (NHL) and market trends in the 6MM, i.e.,&nbsp;United States&nbsp;and EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France&nbsp;and&nbsp;United Kingdom).<\/p>\n<p style=\"text-align: justify;\"><strong>Peripheral T Cell Lymphoma Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &lsquo;<strong>Peripheral T-Cell Lymphoma Market Insights, Epidemiology and Market Forecast&ndash;2030<\/strong>&lsquo; report delivers an in-depth understanding of the PTCL, historical and forecasted epidemiology as well as the PTCL market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Relapsed Chronic Lymphocytic Leukemia Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Relapsed Chronic Lymphocytic Leukemia (CLL) Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Relapsed Chronic Lymphocytic Leukemia (CLL), historical and forecasted epidemiology as well as the Relapsed Chronic Lymphocytic Leukemia (CLL) market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Small Lymphocytic Lymphoma Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Small lymphocytic lymphoma Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Small lymphocytic lymphoma, historical and forecasted epidemiology as well as the Small lymphocytic lymphoma market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Synovial Sarcoma Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Synovial Sarcoma, historical and forecasted epidemiology as well as the Synovial Sarcoma market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Uveal Neoplasms Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Uveal Neoplasms Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Uveal Neoplasms, historical and forecasted epidemiology as well as the Uveal Neoplasms market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Market<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Thyroid Cancer Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Thyroid Cancer, historical and forecasted epidemiology as well as the Thyroid Cancer market trends in&nbsp;the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=degenerative-disc-disease-market-industry-analysis-and-growth-size-share-trends-opportunities-top-key-players-discgenics-mesoblastgruenthal-kuros-biosciences-ankasa-therapeutics-etc\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=degenerative-disc-disease-market-industry-analysis-and-growth-size-share-trends-opportunities-top-key-players-discgenics-mesoblastgruenthal-kuros-biosciences-ankasa-therapeutics-etc\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Degenerative Disc Disease Market (Albany, US) DelveInsight&#8217;s &#8220;Degenerative Disc Disease Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Degenerative Disc Disease (DDD) , historical and forecasted epidemiology as well as the Degenerative Disc Disease (DDD) &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/degenerative-disc-disease-market-industry-analysis-and-growth-size-share-trends-opportunities-top-key-players-discgenics-mesoblastgruenthal-kuros-biosciences-ankasa-therapeutics-etc_532396.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,413],"tags":[],"class_list":["post-532396","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/532396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=532396"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/532396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=532396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=532396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=532396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}